|
AASDHPPT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.518800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.212100E-02 |
| Normal-vs-Stage2 |
5.690400E-02 |
| Normal-vs-Stage3 |
1.805100E-04 |
| Normal-vs-Stage4 |
1.1124000000029E-06 |
| Stage1-vs-Stage2 |
8.363000E-01 |
| Stage1-vs-Stage3 |
9.975400E-03 |
| Stage1-vs-Stage4 |
1.187630E-04 |
| Stage2-vs-Stage3 |
1.164210E-01 |
| Stage2-vs-Stage4 |
7.259000E-03 |
| Stage3-vs-Stage4 |
1.977790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.395670E-03 |
| Normal-vs-AfricanAmerican |
1.575570E-01 |
| Normal-vs-Asian |
2.201700E-02 |
| Caucasian-vs-AfricanAmerican |
5.568000E-01 |
| Caucasian-vs-Asian |
6.944800E-01 |
| AfricanAmerican-vs-Asian |
8.134600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.389100E-04 |
| Normal-vs-Female |
7.677800E-03 |
| Male-vs-Female |
1.161550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.486400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.401230E-03 |
| Normal-vs-Age(61-80Yrs) |
6.018700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.256400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.005990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.901800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.954390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.210200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.075600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.572800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.530410E-01 |
| Classical-VS-Follicular |
7.829400E-01 |
| Classical-VS-Other |
8.879800E-01 |
| Classical-VS-Normal |
1.098420E-02 |
| Tall-VS-Follicular |
1.567770E-01 |
| Tall-VS-Other |
5.261600E-01 |
| Tall-VS-Normal |
2.443200E-03 |
| Follicular-VS-Other |
8.291000E-01 |
| Follicular-VS-Normal |
5.416200E-02 |
| Other-VS-Normal |
2.380800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.135400E-03 |
| Normal-vs-N1 |
2.004600E-04 |
| N0-vs-N1 |
1.276180E-01 |
|
|
